SC 13G Filing

Company

Vanda Pharmaceuticals Inc.

Filed

March 5, 2009

Accession Number

0001144204-09-012221

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →